Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 27.35B | 26.31B | 26.13B | 23.87B | 21.83B |
Gross Profit | 6.74B | 5.92B | 5.32B | 5.22B | 5.11B |
EBITDA | 3.22B | 2.44B | 2.56B | 2.68B | 2.43B |
Net Income | 1.19B | 182.15M | 760.68M | 946.79M | 1.16B |
Balance Sheet | |||||
Total Assets | 38.34B | 36.48B | 38.12B | 32.14B | 31.36B |
Cash, Cash Equivalents and Short-Term Investments | 5.93B | 4.53B | 9.35B | 4.05B | 5.68B |
Total Debt | 8.80B | 8.10B | 6.80B | 2.30B | 1.80B |
Total Liabilities | 14.60B | 13.71B | 12.38B | 7.18B | 7.02B |
Stockholders Equity | 23.38B | 22.29B | 25.32B | 24.58B | 23.98B |
Cash Flow | |||||
Free Cash Flow | 1.24B | -1.87B | 1.61B | -1.67B | 1.14B |
Operating Cash Flow | 3.56B | -271.66M | 2.47B | 196.10M | 2.52B |
Investing Cash Flow | -2.57B | -2.09B | -1.42B | -2.04B | -1.41B |
Financing Cash Flow | 305.30M | -2.55B | 4.18B | 163.73M | -210.30M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥18.09B | 8.08 | 3.45% | 2.21% | -5.13% | ||
80 Outperform | ¥14.88B | 8.41 | 3.26% | 3.59% | 249.94% | ||
73 Outperform | ¥18.30B | 21.90 | 1.11% | 17.04% | 25.79% | ||
72 Outperform | ¥11.22B | 6.65 | 1.61% | 20.12% | 17.45% | ||
64 Neutral | $11.06B | 17.35 | 5.95% | 2.05% | 2.69% | -18.87% | |
60 Neutral | ¥12.05B | 109.72 | 4.66% | -17.49% | -96.33% |